Global Personalized Cancer Medicine Market Size, Share, Growth Drivers, Opportunities and Forecast To 2030

Global Personalized Cancer Medicine Market Size, Share, Growth Drivers, Opportunities and Forecast To 2030
Report Category: Pharma and Healthcare
SKU: PMR-120986  Published Date: 2024-01-03   Pages:108   Delivery Format:


CHOOSE LICENSE TYPE





PMR Research.

Market Executive Summary

Personalized Cancer Medicine Market Size

The global Personalized Cancer Medicine market was valued at US$ 161690 million in 2023 and is anticipated to reach US$ 350430 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.

In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified on the basis of treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.

Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.

Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient's cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.

Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient's immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor's molecular characteristics.

This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Medicine.

Report Scope

The Personalized Cancer Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalized Cancer Medicine market comprehensively. Regional market sizes, concerning products by Method, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Method, by Application, and by regions.

Market Segmentation

Global Personalized Cancer Medicine Companies Covered

AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine

Global Personalized Cancer Medicine Market, Segment by Type

Cancer Immunotherapy

Targeted Therapy

Global Personalized Cancer Medicine Market, Segment by Application

Lung Cancer

Breast Cancer

Prostate Cancer

Blood-related Cancer

Other

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Method, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Method, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.



Table of Contents

1 Report Overview

    1.1 Study Scope

    1.2 Market Analysis by Method

        1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Method: 2019 VS 2023 VS 2030

        1.2.2 Cancer Immunotherapy

        1.2.3 Targeted Therapy

    1.3 Market by Application

        1.3.1 Global Personalized Cancer Medicine Market Growth by Application: 2019 VS 2023 VS 2030

        1.3.2 Lung Cancer

        1.3.3 Breast Cancer

        1.3.4 Prostate Cancer

        1.3.5 Blood-related Cancer

        1.3.6 Other

    1.4 Study Objectives

    1.5 Years Considered

    1.6 Years Considered

 2 Global Growth Trends

    2.1 Global Personalized Cancer Medicine Market Perspective (2019-2030)

    2.2 Personalized Cancer Medicine Growth Trends by Region

        2.2.1 Global Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

        2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2019-2024)

        2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030)

    2.3 Personalized Cancer Medicine Market Dynamics

        2.3.1 Personalized Cancer Medicine Industry Trends

        2.3.2 Personalized Cancer Medicine Market Drivers

        2.3.3 Personalized Cancer Medicine Market Challenges

        2.3.4 Personalized Cancer Medicine Market Restraints

 3 Competition Landscape by Key Players

    3.1 Global Top Personalized Cancer Medicine Players by Revenue

        3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2019-2024)

        3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)

    3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

    3.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue

    3.4 Global Personalized Cancer Medicine Market Concentration Ratio

        3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)

        3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2023

    3.5 Personalized Cancer Medicine Key Players Head office and Area Served

    3.6 Key Players Personalized Cancer Medicine Product Solution and Service

    3.7 Date of Enter into Personalized Cancer Medicine Market

    3.8 Mergers & Acquisitions, Expansion Plans

 4 Personalized Cancer Medicine Breakdown Data by Method

    4.1 Global Personalized Cancer Medicine Historic Market Size by Method (2019-2024)

    4.2 Global Personalized Cancer Medicine Forecasted Market Size by Method (2025-2030)

 5 Personalized Cancer Medicine Breakdown Data by Application

    5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2019-2024)

    5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030)

 6 North America

    6.1 North America Personalized Cancer Medicine Market Size (2019-2030)

    6.2 North America Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

    6.3 North America Personalized Cancer Medicine Market Size by Country (2019-2024)

    6.4 North America Personalized Cancer Medicine Market Size by Country (2025-2030)

    6.5 United States

    6.6 Canada

 7 Europe

    7.1 Europe Personalized Cancer Medicine Market Size (2019-2030)

    7.2 Europe Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

    7.3 Europe Personalized Cancer Medicine Market Size by Country (2019-2024)

    7.4 Europe Personalized Cancer Medicine Market Size by Country (2025-2030)

    7.5 Germany

    7.6 France

    7.7 U.K.

    7.8 Italy

    7.9 Russia

    7.10 Nordic Countries

 8 Asia-Pacific

    8.1 Asia-Pacific Personalized Cancer Medicine Market Size (2019-2030)

    8.2 Asia-Pacific Personalized Cancer Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

    8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2019-2024)

    8.4 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2025-2030)

    8.5 China

    8.6 Japan

    8.7 South Korea

    8.8 Southeast Asia

    8.9 India

    8.10 Australia

 9 Latin America

    9.1 Latin America Personalized Cancer Medicine Market Size (2019-2030)

    9.2 Latin America Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

    9.3 Latin America Personalized Cancer Medicine Market Size by Country (2019-2024)

    9.4 Latin America Personalized Cancer Medicine Market Size by Country (2025-2030)

    9.5 Mexico

    9.6 Brazil

 10 Middle East & Africa

    10.1 Middle East & Africa Personalized Cancer Medicine Market Size (2019-2030)

    10.2 Middle East & Africa Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

    10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2019-2024)

    10.4 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2025-2030)

    10.5 Turkey

    10.6 Saudi Arabia

    10.7 UAE

 11 Key Players Profiles

    11.1 AbbVie

        11.1.1 AbbVie Company Detail

        11.1.2 AbbVie Business Overview

        11.1.3 AbbVie Personalized Cancer Medicine Introduction

        11.1.4 AbbVie Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.1.5 AbbVie Recent Development

    11.2 Johnson & Johnson

        11.2.1 Johnson & Johnson Company Detail

        11.2.2 Johnson & Johnson Business Overview

        11.2.3 Johnson & Johnson Personalized Cancer Medicine Introduction

        11.2.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.2.5 Johnson & Johnson Recent Development

    11.3 Novartis

        11.3.1 Novartis Company Detail

        11.3.2 Novartis Business Overview

        11.3.3 Novartis Personalized Cancer Medicine Introduction

        11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.3.5 Novartis Recent Development

    11.4 Gilead Sciences

        11.4.1 Gilead Sciences Company Detail

        11.4.2 Gilead Sciences Business Overview

        11.4.3 Gilead Sciences Personalized Cancer Medicine Introduction

        11.4.4 Gilead Sciences Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.4.5 Gilead Sciences Recent Development

    11.5 Roche

        11.5.1 Roche Company Detail

        11.5.2 Roche Business Overview

        11.5.3 Roche Personalized Cancer Medicine Introduction

        11.5.4 Roche Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.5.5 Roche Recent Development

    11.6 Bristol-Myers Squibb

        11.6.1 Bristol-Myers Squibb Company Detail

        11.6.2 Bristol-Myers Squibb Business Overview

        11.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Introduction

        11.6.4 Bristol-Myers Squibb Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.6.5 Bristol-Myers Squibb Recent Development

    11.7 Amgen

        11.7.1 Amgen Company Detail

        11.7.2 Amgen Business Overview

        11.7.3 Amgen Personalized Cancer Medicine Introduction

        11.7.4 Amgen Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.7.5 Amgen Recent Development

    11.8 AstraZeneca

        11.8.1 AstraZeneca Company Detail

        11.8.2 AstraZeneca Business Overview

        11.8.3 AstraZeneca Personalized Cancer Medicine Introduction

        11.8.4 AstraZeneca Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.8.5 AstraZeneca Recent Development

    11.9 Merck & Co

        11.9.1 Merck & Co Company Detail

        11.9.2 Merck & Co Business Overview

        11.9.3 Merck & Co Personalized Cancer Medicine Introduction

        11.9.4 Merck & Co Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.9.5 Merck & Co Recent Development

    11.10 Takeda

        11.10.1 Takeda Company Detail

        11.10.2 Takeda Business Overview

        11.10.3 Takeda Personalized Cancer Medicine Introduction

        11.10.4 Takeda Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.10.5 Takeda Recent Development

    11.11 Merck KGaA

        11.11.1 Merck KGaA Company Detail

        11.11.2 Merck KGaA Business Overview

        11.11.3 Merck KGaA Personalized Cancer Medicine Introduction

        11.11.4 Merck KGaA Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.11.5 Merck KGaA Recent Development

    11.12 Seagen

        11.12.1 Seagen Company Detail

        11.12.2 Seagen Business Overview

        11.12.3 Seagen Personalized Cancer Medicine Introduction

        11.12.4 Seagen Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.12.5 Seagen Recent Development

    11.13 Eli Lilly

        11.13.1 Eli Lilly Company Detail

        11.13.2 Eli Lilly Business Overview

        11.13.3 Eli Lilly Personalized Cancer Medicine Introduction

        11.13.4 Eli Lilly Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.13.5 Eli Lilly Recent Development

    11.14 Ono Pharmaceutical

        11.14.1 Ono Pharmaceutical Company Detail

        11.14.2 Ono Pharmaceutical Business Overview

        11.14.3 Ono Pharmaceutical Personalized Cancer Medicine Introduction

        11.14.4 Ono Pharmaceutical Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.14.5 Ono Pharmaceutical Recent Development

    11.15 Pfizer

        11.15.1 Pfizer Company Detail

        11.15.2 Pfizer Business Overview

        11.15.3 Pfizer Personalized Cancer Medicine Introduction

        11.15.4 Pfizer Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.15.5 Pfizer Recent Development

    11.16 GSK

        11.16.1 GSK Company Detail

        11.16.2 GSK Business Overview

        11.16.3 GSK Personalized Cancer Medicine Introduction

        11.16.4 GSK Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.16.5 GSK Recent Development

    11.17 Exelixis

        11.17.1 Exelixis Company Detail

        11.17.2 Exelixis Business Overview

        11.17.3 Exelixis Personalized Cancer Medicine Introduction

        11.17.4 Exelixis Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.17.5 Exelixis Recent Development

    11.18 Regeneron

        11.18.1 Regeneron Company Detail

        11.18.2 Regeneron Business Overview

        11.18.3 Regeneron Personalized Cancer Medicine Introduction

        11.18.4 Regeneron Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.18.5 Regeneron Recent Development

    11.19 Innovent

        11.19.1 Innovent Company Detail

        11.19.2 Innovent Business Overview

        11.19.3 Innovent Personalized Cancer Medicine Introduction

        11.19.4 Innovent Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.19.5 Innovent Recent Development

    11.20 Hengrui Medicine

        11.20.1 Hengrui Medicine Company Detail

        11.20.2 Hengrui Medicine Business Overview

        11.20.3 Hengrui Medicine Personalized Cancer Medicine Introduction

        11.20.4 Hengrui Medicine Revenue in Personalized Cancer Medicine Business (2019-2024)

        11.20.5 Hengrui Medicine Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix

    13.1 Research Methodology

        13.1.1 Methodology/Research Approach

        13.1.2 Data Source

    13.2 Disclaimer

    13.3 Author Details



List of Figures

List of Tables

    Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Method (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Cancer Immunotherapy

    Table 3. Key Players of Targeted Therapy

    Table 4. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 5. Global Personalized Cancer Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

    Table 7. Global Personalized Cancer Medicine Market Share by Region (2019-2024)

    Table 8. Global Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 9. Global Personalized Cancer Medicine Market Share by Region (2025-2030)

    Table 10. Personalized Cancer Medicine Market Trends

    Table 11. Personalized Cancer Medicine Market Drivers

    Table 12. Personalized Cancer Medicine Market Challenges

    Table 13. Personalized Cancer Medicine Market Restraints

    Table 14. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)

    Table 15. Global Personalized Cancer Medicine Market Share by Players (2019-2024)

    Table 16. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)

    Table 17. Ranking of Global Top Personalized Cancer Medicine Companies by Revenue (US$ Million) in 2023

    Table 18. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Personalized Cancer Medicine Product Solution and Service

    Table 21. Date of Enter into Personalized Cancer Medicine Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Personalized Cancer Medicine Market Size by Method (2019-2024) & (US$ Million)

    Table 24. Global Personalized Cancer Medicine Revenue Market Share by Method (2019-2024)

    Table 25. Global Personalized Cancer Medicine Forecasted Market Size by Method (2025-2030) & (US$ Million)

    Table 26. Global Personalized Cancer Medicine Revenue Market Share by Method (2025-2030)

    Table 27. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

    Table 28. Global Personalized Cancer Medicine Revenue Market Share by Application (2019-2024)

    Table 29. Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 30. Global Personalized Cancer Medicine Revenue Market Share by Application (2025-2030)

    Table 31. North America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 32. North America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

    Table 33. North America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

    Table 34. Europe Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 35. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

    Table 36. Europe Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

    Table 37. Asia-Pacific Personalized Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 38. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

    Table 39. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 41. Latin America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

    Table 42. Latin America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

    Table 43. Middle East & Africa Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 44. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

    Table 45. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

    Table 46. AbbVie Company Detail

    Table 47. AbbVie Business Overview

    Table 48. AbbVie Personalized Cancer Medicine Product

    Table 49. AbbVie Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 50. AbbVie Recent Development

    Table 51. Johnson & Johnson Company Detail

    Table 52. Johnson & Johnson Business Overview

    Table 53. Johnson & Johnson Personalized Cancer Medicine Product

    Table 54. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 55. Johnson & Johnson Recent Development

    Table 56. Novartis Company Detail

    Table 57. Novartis Business Overview

    Table 58. Novartis Personalized Cancer Medicine Product

    Table 59. Novartis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 60. Novartis Recent Development

    Table 61. Gilead Sciences Company Detail

    Table 62. Gilead Sciences Business Overview

    Table 63. Gilead Sciences Personalized Cancer Medicine Product

    Table 64. Gilead Sciences Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 65. Gilead Sciences Recent Development

    Table 66. Roche Company Detail

    Table 67. Roche Business Overview

    Table 68. Roche Personalized Cancer Medicine Product

    Table 69. Roche Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 70. Roche Recent Development

    Table 71. Bristol-Myers Squibb Company Detail

    Table 72. Bristol-Myers Squibb Business Overview

    Table 73. Bristol-Myers Squibb Personalized Cancer Medicine Product

    Table 74. Bristol-Myers Squibb Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 75. Bristol-Myers Squibb Recent Development

    Table 76. Amgen Company Detail

    Table 77. Amgen Business Overview

    Table 78. Amgen Personalized Cancer Medicine Product

    Table 79. Amgen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 80. Amgen Recent Development

    Table 81. AstraZeneca Company Detail

    Table 82. AstraZeneca Business Overview

    Table 83. AstraZeneca Personalized Cancer Medicine Product

    Table 84. AstraZeneca Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 85. AstraZeneca Recent Development

    Table 86. Merck & Co Company Detail

    Table 87. Merck & Co Business Overview

    Table 88. Merck & Co Personalized Cancer Medicine Product

    Table 89. Merck & Co Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 90. Merck & Co Recent Development

    Table 91. Takeda Company Detail

    Table 92. Takeda Business Overview

    Table 93. Takeda Personalized Cancer Medicine Product

    Table 94. Takeda Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 95. Takeda Recent Development

    Table 96. Merck KGaA Company Detail

    Table 97. Merck KGaA Business Overview

    Table 98. Merck KGaA Personalized Cancer Medicine Product

    Table 99. Merck KGaA Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 100. Merck KGaA Recent Development

    Table 101. Seagen Company Detail

    Table 102. Seagen Business Overview

    Table 103. Seagen Personalized Cancer Medicine Product

    Table 104. Seagen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 105. Seagen Recent Development

    Table 106. Eli Lilly Company Detail

    Table 107. Eli Lilly Business Overview

    Table 108. Eli Lilly Personalized Cancer Medicine Product

    Table 109. Eli Lilly Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 110. Eli Lilly Recent Development

    Table 111. Ono Pharmaceutical Company Detail

    Table 112. Ono Pharmaceutical Business Overview

    Table 113. Ono Pharmaceutical Personalized Cancer Medicine Product

    Table 114. Ono Pharmaceutical Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 115. Ono Pharmaceutical Recent Development

    Table 116. Pfizer Company Detail

    Table 117. Pfizer Business Overview

    Table 118. Pfizer Personalized Cancer Medicine Product

    Table 119. Pfizer Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 120. Pfizer Recent Development

    Table 121. GSK Company Detail

    Table 122. GSK Business Overview

    Table 123. GSK Personalized Cancer Medicine Product

    Table 124. GSK Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 125. GSK Recent Development

    Table 126. Exelixis Company Detail

    Table 127. Exelixis Business Overview

    Table 128. Exelixis Personalized Cancer Medicine Product

    Table 129. Exelixis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 130. Exelixis Recent Development

    Table 131. Regeneron Company Detail

    Table 132. Regeneron Business Overview

    Table 133. Regeneron Personalized Cancer Medicine Product

    Table 134. Regeneron Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 135. Regeneron Recent Development

    Table 136. Innovent Company Detail

    Table 137. Innovent Business Overview

    Table 138. Innovent Personalized Cancer Medicine Product

    Table 139. Innovent Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 140. Innovent Recent Development

    Table 141. Hengrui Medicine Company Detail

    Table 142. Hengrui Medicine Business Overview

    Table 143. Hengrui Medicine Personalized Cancer Medicine Product

    Table 144. Hengrui Medicine Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

    Table 145. Hengrui Medicine Recent Development

    Table 146. Research Programs/Design for This Report

    Table 147. Key Data Information from Secondary Sources

    Table 148. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Personalized Cancer Medicine Market Size Comparison by Method (2024-2030) & (US$ Million)

    Figure 2. Global Personalized Cancer Medicine Market Share by Method: 2023 VS 2030

    Figure 3. Cancer Immunotherapy Features

    Figure 4. Targeted Therapy Features

    Figure 5. Global Personalized Cancer Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 6. Global Personalized Cancer Medicine Market Share by Application: 2023 VS 2030

    Figure 7. Lung Cancer Case Studies

    Figure 8. Breast Cancer Case Studies

    Figure 9. Prostate Cancer Case Studies

    Figure 10. Blood-related Cancer Case Studies

    Figure 11. Other Case Studies

    Figure 12. Personalized Cancer Medicine Report Years Considered

    Figure 13. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 14. Global Personalized Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 15. Global Personalized Cancer Medicine Market Share by Region: 2023 VS 2030

    Figure 16. Global Personalized Cancer Medicine Market Share by Players in 2023

    Figure 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)

    Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2023

    Figure 19. North America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 20. North America Personalized Cancer Medicine Market Share by Country (2019-2030)

    Figure 21. United States Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Canada Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 24. Europe Personalized Cancer Medicine Market Share by Country (2019-2030)

    Figure 25. Germany Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. France Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. U.K. Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Italy Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Russia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. Asia-Pacific Personalized Cancer Medicine Market Share by Region (2019-2030)

    Figure 33. China Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. Japan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. South Korea Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. India Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Australia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 40. Latin America Personalized Cancer Medicine Market Share by Country (2019-2030)

    Figure 41. Mexico Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Brazil Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. Middle East & Africa Personalized Cancer Medicine Market Share by Country (2019-2030)

    Figure 45. Turkey Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 47. AbbVie Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 48. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 49. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 50. Gilead Sciences Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 51. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 53. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 54. AstraZeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 55. Merck & Co Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 56. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 57. Merck KGaA Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 58. Seagen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 59. Eli Lilly Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 60. Ono Pharmaceutical Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 61. Pfizer Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 62. GSK Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 63. Exelixis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 64. Regeneron Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 65. Innovent Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 66. Hengrui Medicine Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed


We can offer customized data and information to meet our clients need.

This report focuses on:

► Intelligent insights to take informed business decisions.

► Qualitative and quantitative analysis of the market.

► Market size and forecasts from 2024 to 2030.

► Opportunities for expansion and in-depth market analysis.

► Segmentation and regional revenue forecasts.

► Analysis of the market share and competitive landscape.

► Strategic recommendations for future growth.


You'll also receive:

► A comprehensive market research report in PDF or PPT formats.

► Access to our analysts to learn more about the report and get answers to your specific business questions.

► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.


Contact us today to learn more and get sample report.


Our Research Reports Look Like This
Pragma Market Research Sample

Covid-19 Impact Duns and Brad Badge
up